237 related articles for article (PubMed ID: 23101999)
1. The effect of antifibrinolytic prophylaxis on postoperative outcomes in patients undergoing cardiac operations.
Koul A; Ferraris V; Davenport DL; Ramaiah C
Int Surg; 2012; 97(1):34-42. PubMed ID: 23101999
[TBL] [Abstract][Full Text] [Related]
2. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
[TBL] [Abstract][Full Text] [Related]
4. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.
Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ
Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383
[TBL] [Abstract][Full Text] [Related]
5. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery bypass grafting after aprotinin: are we doing better?
Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
[TBL] [Abstract][Full Text] [Related]
7. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
Henry D; Carless P; Fergusson D; Laupacis A
CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
Li G; Sun TW; Luo G; Zhang C
Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
[TBL] [Abstract][Full Text] [Related]
9. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
10. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
[TBL] [Abstract][Full Text] [Related]
11. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G
Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
Siemens K; Sangaran DP; Hunt BJ; Murdoch IA; Tibby SM
Anesth Analg; 2022 May; 134(5):987-1001. PubMed ID: 34633994
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
[TBL] [Abstract][Full Text] [Related]
14. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
[TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG
J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis of blood loss and allogenic blood transfusion with fibrinolysis inhibitors produced in Russian Federation in patients undergoing cardiac surgery].
Bitkova EE; Timerbayev VH; Hvatov VB; Zvereva NY; Chumakov MV; Shumckii KY
Anesteziol Reanimatol; 2014; (2):59-64. PubMed ID: 25055497
[TBL] [Abstract][Full Text] [Related]
20. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
